Literature DB >> 34203145

Trends of Stomach Cancer in Central Serbia.

Miodrag M Stojanovic1, Natasa K Rancic1, Marija R Andjelkovic Apostolovic1, Aleksandra M Ignjatovic1, Mirko V Ilic1.   

Abstract

Somach cancer is the third most common cause of cancer-related deaths worldwide. The objective of the paper was to analyze the incidence and mortality trends of stomach cancer in Central Serbia in the period between 1999-2017. Materials and
Methods: trends and annual percentage change (APC) of the incidence and mortality rate with corresponding 95% confidence intervals (CI) were calculated by joinpoint regression analyses. The optimal number of Joinpoints was identified using the Monte Carlo permutation method. The trend was considered to be significantly increasing (positive change) or decreasing (negative change) when the p-value was below 0.05 (p < 0.05).
Results: the total number of new cases was 16,914 (10,873 males and 6041 females) and the total number of mortality cases was 14,790 (9348 in and 5442 in females). Almost one third (30.8%) of new cases were registered in the 60-69-year age group, and new cases were significantly more frequent in males than in females (30.8% vs. 29.02%, p < 0.001). Joinpoint regression analysis showed a significant decrease of incidence trend in females during the 2000-2015 period with APC of -2.13% (95% CI: -3.8 to -0.5, p < 0.001). An insignificant decrease in incidence trend was in males with APC of -0.72% (95% CI: -2.3 to 0.9, p = 0.30). According to the joinpoint analysis, a significant decrease of mortality trends both in males during 2000-2015 with APC of -2.21% (95% CI: -1.6 to -7.5, p ≤ 0.001 and in females, during the same period, with APC of -1.75% (95% CI: -2.9 to -0.6, p < 0.001) was registered. From 2015 to 2017, a significant increase of mortality was registered with APC of 44.5% (95% CI: from 24.2 to -68.1, p ≤ 0.001) in females and in males with APC of 53.15% (95% CI: 13.5 to -106.6, p ≤ 0.001).
Conclusion: a significant decrease of stomach cancer incidence trend in females and insignificant decrease of incidence trend in males were determined in Central Serbia. Based on presented results, the mortality trend decreased significantly both in males and in females during 2000-2015, and from 2015 to 2017 we recorded a significant increase in mortality in both sexes. We found significantly more new cases in women than in men in the age group of 40-49, and the mortality of stomach cancer was significantly more frequent among females compared to males in the age groups 30-39, as well as in the 50-59 age group. There is a need for improving recording and registration of new cases of stomach cancer, especially in females. Urgent primary and secondary preventive measures are needed-introducing stomach cancer screening and early detection of premalignant changes. Urgent primary and secondary preventive measures are needed.

Entities:  

Keywords:  incidence; mortality; stomach cancer; trend

Mesh:

Year:  2021        PMID: 34203145     DOI: 10.3390/medicina57070665

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  16 in total

1.  Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline.

Authors:  R H Hunt; S D Xiao; F Megraud; R Leon-Barua; F Bazzoli; S van der Merwe; L G Vaz Coelho; M Fock; S Fedail; H Cohen; P Malfertheiner; N Vakil; S Hamid; K L Goh; B C Y Wong; J Krabshuis; A Le Mair
Journal:  J Gastrointestin Liver Dis       Date:  2011-09       Impact factor: 2.008

2.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

Review 3.  Changing Trends in Stomach Cancer Throughout the World.

Authors:  Maya Balakrishnan; Rollin George; Ashish Sharma; David Y Graham
Journal:  Curr Gastroenterol Rep       Date:  2017-08

Review 4.  Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention.

Authors:  Parisa Karimi; Farhad Islami; Sharmila Anandasabapathy; Neal D Freedman; Farin Kamangar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03-11       Impact factor: 4.254

5.  Evaluation of Helicobacter pylori infection in patients with eso-gastro-duodenal pathology.

Authors:  Lavinia Olar; Paul MitruŢ; Charoula Florou; Gheorghe Dan Mălăescu; Octavian Ion Predescu; Liliana Marcela Rogozea; LaurenŢiu Mogoantă; Nina Ionovici; Ionica Pirici
Journal:  Rom J Morphol Embryol       Date:  2017       Impact factor: 1.033

Review 6.  Helicobacter pylori and gastric cancer: factors that modulate disease risk.

Authors:  Lydia E Wroblewski; Richard M Peek; Keith T Wilson
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

7.  Burden of cancer in Serbia.

Authors:  Hristina Vlajinac; Sandra Sipetić-Grujicić; Slavenka Janković; Jelena Marinković; Nikola Kocev; Ljiljana Marković-Denić; Vesna Bjegović
Journal:  Croat Med J       Date:  2006-02       Impact factor: 1.351

8.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

9.  Alcohol consumption and risk of gastric cancer: a cohort study of men in Kaunas, Lithuania, with up to 30 years follow-up.

Authors:  Ruta Everatt; Abdonas Tamosiunas; Irena Kuzmickiene; Dalia Virviciute; Ricardas Radisauskas; Regina Reklaitiene; Egle Milinaviciene
Journal:  BMC Cancer       Date:  2012-10-15       Impact factor: 4.430

10.  Cancer incidence and mortality in Serbia 1999-2009.

Authors:  Jovan Mihajlović; Petros Pechlivanoglou; Marica Miladinov-Mikov; Snežana Zivković; Maarten J Postma
Journal:  BMC Cancer       Date:  2013-01-15       Impact factor: 4.430

View more
  1 in total

1.  Development of web-based dynamic nomogram to predict survival in patients with gastric cancer: a population-based study.

Authors:  Atefeh Talebi; Nasrin Borumandnia; Hassan Doosti; Somayeh Abbasi; Mohamad Amin Pourhoseingholi; Shahram Agah; Seidamir Pasha Tabaeian
Journal:  Sci Rep       Date:  2022-03-17       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.